Cybin Inc., a clinical-stage neuropsychiatry company, has announced a manufacturing partnership with Thermo Fisher Scientific to support the advancement of CYB003, its proprietary deuterated psilocin therapy for Major Depressive Disorder (MDD). The agreement covers Phase 3 clinical supply and potential
RoosterBio, Inc., a supplier of human mesenchymal stem/stromal cells (hMSCs), media, and bioprocess services, has announced a collaboration with Thermo Fisher Scientific to accelerate the development and manufacturing of cell and exosome therapies targeting degenerative diseases. The partnership aims to
Thermo Fisher Scientific Inc., a major global player in the life sciences sector, has announced plans to invest $2 billion in its U.S. operations over the next four years. The investment is aimed at bolstering American innovation, enhancing manufacturing capacity,
Thermo Fisher Scientific Inc. has signed a definitive agreement to acquire Solventum’s Purification & Filtration business for approximately $4.1 billion in cash. The deal, expected to close by the end of 2025, will enhance Thermo Fisher’s bioproduction capabilities and expand its filtration technology offerings.
Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has announced a strategic collaboration with Thermo Fisher Scientific to advance its long-acting oral therapies. This partnership will see Thermo Fisher providing clinical research and global commercial manufacturing services, supporting Lyndra’s innovative approach to
“The industry is back, and we’re uniquely positioned to provide end-to-end services, including clinical trials. That’s what we mean by CDMO plus CRO – it’s a complete 360-degree set of operations,” says Dr. Anil Kane, Executive Director and Global Head
Thermo Fisher Scientific has announced its new Accelerator Drug Development platform, designed to offer 360° contract development and manufacturing organisation (CDMO) and contract research organisation (CRO) solutions to support the pharmaceutical industry. A CPHI Milan 2024, Thermo Fisher will highlight
DHL Express and Thermo Fisher Scientific’s PPD clinical research business have announced a partnership aimed at reducing the environmental impact of global clinical research logistics. The collaboration will leverage DHL’s GoGreen Plus service and use sustainable aviation fuel (SAF) to
Thermo Fisher Scientific has announced a $22-million investment across its Cincinnati, Ohio, and Bend, Oregon facilities to expand their oral solid dose (OSD) capabilities. The move, initiated in 2021, aims to enhance the research, development, manufacturing, and testing of OSD
Thermo Fisher Scientific has announced the establishment of a new bioanalytical laboratory in GoCo Health Innovation City, Gothenburg, Sweden. This 29,000-square-foot facility, located next to AstraZeneca’s strategic research site, will enhance the company’s global laboratory services. The new lab will
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
